Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Deutsche Bank Q1 Profit Dips - Quick Facts

RELATED NEWS
Trade DB now with 

German financial services giant Deutsche Bank (DB: Quote) posted a drop in first-quarter net income to 1.4 billion euros from 2.1 billion euros in the prior-year quarter, with quarterly earnings per share falling to 1.44 euros from last year's 2.13 euros a year ago.

The company stated, "We continue to pursue our strategy of reducing legacy risks and strengthening our capital position, as evidenced by our disposal of Actavis and ongoing progress on litigation issues."

In the Corporate & Investment Bank, net revenues slid 8% in the 2012 first quarter to 6.2 billion euros from 6.7 billion euros in the first quarter 2011.

Click here to receive FREE breaking news email alerts for Deutsche Bank AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that its third quarter loss widened slightly from last year, as higher costs and expenses more than offset a 45% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. After ending the previous session modestly lower, stocks moved mostly higher over the course of the trading day on Thursday. The gains on the day more than offset yesterday's losses, lifting the major averages to their best closing levels in a month. Sen. Lindsey Graham, R-S.C., is seen as a long shot for the Republican presidential nomination in 2016, and his chances may have gotten worse after he was recorded joking about the prospects for "white men" if he were elected president.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.